In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

AngioDynamics Inc.

www.angiodynamics.com

Latest From AngioDynamics Inc.

AngioDynamics Off-Loads Namic Fluid-Management Business To Medline

Medline Industries will pay $167.5m for the Namic brand of manifolds, contrast management systems, closed fluid systems, guidewires, disposable transducers and interventional accessories. It also includes a manufacturing facility and the manufacturing, sales and marketing staff that support Namic.

 
Deals M & A

Device Settlements Contribute To DoJ's $2.5Bn Health-Care FCA Haul

The US Department of Justice collected $2.8bn in settlements and judgments involving violations of the False Claims Act in 2018, including $2.5bn in health-care cases. Key device industry recoveries included $33.2m from Alere, $12.5m from Angiodynamics, and $30m in two separate settlements from Covidien and its subsidiary ev3.

Medical Device Legal Issues

Market Intel: New Thermal Therapies Blaze Trail In Fast-Growing Cancer Ablation Market

Cancer rates are rising worldwide and as diagnostic techniques continue to improve, new surgical ablation devices are becoming crucial weapons in the growing arsenal of cancer treatment tools. These devices allow doctors to burn away tumors with precision, speed and safety, without the side-effects that patients undergoing radical cancer therapy often experience. This article provides an overview of the cancer ablation market, highlights the key players working on these devices and discusses their potential applications. It also includes critical insights from a leading interventional urologist on the pros and cons of using these various technologies in treating prostate cancer.

Cancer Surgical Procedures

AngioDynamics To Resolve US Federal Claims With $12.5M Payout

Device-maker AngioDynamics has agreed to pay $12.5m to resolve allegations the company encouraged health-care providers to submit false claims for two of the company’s products.

Legal Issues Enforcement
See All

Company Information

  • Industry
  • Medical Devices
    • Consumables, Central Supplies
    • Diagnostic Equipment & Supplies
    • Monitoring Equipment & Devices
    • Radiofrequency Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Pharmaceuticals
    • Radiopharmaceuticals, Contrast Agents
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Renal System
  • Alias(es)
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • AngioDynamics Inc.
  • Senior Management
  • James Clemmer, Pres. & CEO
    Michael Greiner, EVP, CFO
    David D Helsel, SVP, Global Ops. & R&D
  • Contact Info
  • AngioDynamics Inc.
    Phone: (518) 795-1400
    14 Plaza Dr.
    Latham, NY 12110
    USA
Advertisement
Advertisement
UsernamePublicRestriction

Register